Search results (248)
« Back to PublicationsMechanism and Predictive Role of NUB1 Protein in Oestrogen Receptor Pathway of FEC-Treated Breast Cancer Patients.
Journal article
Arshad M. et al, (2025), Biomedicines, 13
Corrigendum to "Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients" [Translational Oncology, volume 49 (2024), 102106].
Journal article
Tan K-L. et al, (2025), Transl Oncol, 55
Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients.
Journal article
Tan K-L. et al, (2024), Transl Oncol, 49
ccessing the vasculature in cancer: revising an old hallmark.
Journal article
Harris AL. et al, (2024), Trends Cancer, 10, 1038 - 1051
On coalescent angiogenesis and the remarkable flexibility of blood vessels.
Journal article
Pezzella F. and Kerbel RS., (2022), Angiogenesis, 25, 1 - 3
Dissecting the heritable risk of breast cancer: From statistical methods to susceptibility genes.
Journal article
Fanfani V. et al, (2021), Semin Cancer Biol, 72, 175 - 184
Early squamous cell lung carcinoma: prognostic biomarkers for the many.
Journal article
Pezzella F., (2019), Thorax, 74, 527 - 528
The Role of JMY in p53 Regulation.
Journal article
Adighibe O. and Pezzella F., (2018), Cancers (Basel), 10
ssociation between hypoxic volume and underlying hypoxia-induced gene expression in oropharyngeal squamous cell carcinoma.
Journal article
Suh Y-E. et al, (2017), Br J Cancer, 116, 1057 - 1064
RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature.
Journal article
Viollet C. et al, (2017), PLoS Pathog, 13
Inhibition of NEDD8 and FAT10 ligase activities through the degrading enzyme NEDD8 ultimate buster 1: A potential anticancer approach.
Journal article
Tan K-L. and Pezzella F., (2016), Oncol Lett, 12, 4287 - 4296
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial.
Journal article
Kerr RS. et al, (2016), Lancet Oncol, 17, 1543 - 1557
Evidence Showing That Tumors Can Grow Without Angiogenesis and Can Switch Between Angiogenic and Nonangiogenic Phenotypes.
Journal article
Pezzella F. and Gatter KC., (2016), J Natl Cancer Inst, 108
Twenty years after: the beautiful hypothesis and the ugly facts.
Journal article
Pezzella F. et al, (2016), Chin J Cancer, 35
